An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help lower their stroke and heart attack risk, a new study has found.

Diabetes is a chronic disease that involves an elevated level of blood sugar. It has a high risk of causing heart disease due to the effects of high blood sugar levels, which damage blood vessels and nerves controlling the heart.

A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional cardiovascular risk factors can also reduce the risk of heart attacks and

A common artificial sweetener may trigger insulin spikes that lead to the build up of fatty plaques in the arteries, increasing the risk of heart attacks and strokes, a new study in mice indicates.

The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk patients with type 2 diabetes (T2D), chronic kidney disease (CKD), and cardiovascular risk factors,

A common artificial sweetener can trigger dangerous insulin spikes, warns a new study. Get a free dose of heath care news and wellness tips delivered to your inbox each Tuesday morning. Powered by North Mississippi Health Services.

Not all artificial sweeteners are created equal. A new study out of Sweden reports that one of the most popular sugar substitutes — found in diet drinks, chewing gum and low-sugar yogurt — increases insulin levels in animals,